Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6
Irene Tsilioni, Anilia Taliou, Konstantinos Francis, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 9, pp. e647-e647
Open Access | Times Cited: 174

Showing 51-75 of 174 citing articles:

Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
Lena Palaniyappan, Min Tae M Park, Peter Jeon, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1703-1703
Open Access | Times Cited: 36
Maternal mid-gestational and child cord blood immune signatures are strongly associated with offspring risk of ASD
Xiaoyu Che, Mady Hornig, Michaeline Bresnahan, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 3, pp. 1527-1541
Open Access | Times Cited: 24
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder
Marianna Tassinari, Nicola Mottolese, Giuseppe Galvani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8719-8719
Open Access | Times Cited: 23
Existing and Future Strategies to Manipulate the Gut Microbiota With Diet as a Potential Adjuvant Treatment for Psychiatric Disorders
Fiona C. Ross, D.E. Mayer, Arpana Gupta, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 4, pp. 348-360
Closed Access | Times Cited: 14
Antioxidant and Anti-Inflammatory Properties of Phytochemicals Found in the Yucca Genus
Erick Bahena Culhuac, Aristide Maggiolino, Mona M. M. Y. Elghandour, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 574-574
Open Access | Times Cited: 13
A Comprehensive Review on Plant-Based Medications and Chemical Approaches for Autism Spectrum Disorders (ASDs) Psychopharmacotherapy
Vrish Dhwaj Ashwlayan, Ratneshwar Kumar Ratnesh, Divya Sharma, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 5
Dietary flavonoids modulate the gut microbiota: A new perspective on improving autism spectrum disorder through the gut-brain axis
H Dai, Yuhan Jiang, Shuxun Liu, et al.
Food Research International (2024) Vol. 186, pp. 114404-114404
Closed Access | Times Cited: 5
Temporal patterns, heterogeneity, and stability of diurnal cortisol rhythms in children with autism spectrum disorder
Andrew J. Tomarken, Gloria T. Han, Blythe A. Corbett
Psychoneuroendocrinology (2015) Vol. 62, pp. 217-226
Open Access | Times Cited: 48
A pilot dose finding study of pioglitazone in autistic children
Lucia Capano, Annie Dupuis, Jessica Brian, et al.
Molecular Autism (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 42
Polyphenols in the management of brain disorders: Modulation of the microbiota-gut-brain axis
Diana Serra, Leonor M. Almeida, Teresa C.P. Dinis
Advances in food and nutrition research (2019), pp. 1-27
Closed Access | Times Cited: 41
Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies
Francesca Pistollato, Tamara Y. Forbes‐Hernández, Rubén Calderón Iglesias, et al.
Pharmacological Research (2019) Vol. 152, pp. 104579-104579
Closed Access | Times Cited: 41
Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway
Thiago Berti Kirsten, Renato Corrêa Viana Casarin, Maria Martha Bernardi, et al.
PLoS ONE (2018) Vol. 13, Iss. 5, pp. e0197060-e0197060
Open Access | Times Cited: 39
The Contribution of Inflammation to Autism Spectrum Disorders: Recent Clinical Evidence
Joana Prata, Ana Sofia Machado, Orlando von Doellinger, et al.
Methods in molecular biology (2019), pp. 493-510
Closed Access | Times Cited: 37
Review of Clinical Studies Targeting Inflammatory Pathways for Individuals With Autism
Sina Hafizi, Dina Tabatabaei, Meng‐Chuan Lai
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 37
IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder
Irene Tsilioni, Harry Pantazopoulos, Pio Conti, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 28, pp. 16475-16480
Open Access | Times Cited: 35
Luteolin inhibits melanoma growth in vitro and in vivo via regulating ECM and oncogenic pathways but not ROS
John Schomberg, Zi Wang, Ahmed Farhat, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 114025-114025
Closed Access | Times Cited: 33
Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey
Meryem Özlem Kütük, Ali Evren Tufan, Cem Gökçen, et al.
Cytokine (2020) Vol. 133, pp. 155152-155152
Closed Access | Times Cited: 33
Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling
Luana Naia, Catarina Moreira Pinho, Giacomo Dentoni, et al.
BMC Biology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Protective effect of olive leaves phenolic compounds against neurodegenerative disorders: Promising alternative for Alzheimer and Parkinson diseases modulation
Fatma Hadrich, Mohamed Chamkha, Sami Sayadi
Food and Chemical Toxicology (2021) Vol. 159, pp. 112752-112752
Closed Access | Times Cited: 30
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Alejandro Delgado, Christos Cholevas, Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 207-217
Closed Access | Times Cited: 29
mTOR Signaling Pathway Regulates the Release of Proinflammatory Molecule CCL5 Implicated in the Pathogenesis of Autism Spectrum Disorder
Baojiang Wang, Yueyuan Qin, Qunyan Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update
Parina Asgharian, Cristina Quispe, Jesús Herrera‐Bravo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Dietary interventions for autism spectrum disorder: An updated systematic review of human studies
Cecilia Nwadiuto Amadi, Chinna N. Orish, Chiara Frazzoli, et al.
Psychiatriki (2022)
Open Access | Times Cited: 19
The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review
Rosa Savino, Alessandro Medoro, Sawan Alì, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3520-3520
Open Access | Times Cited: 12
Exploration of the Core Pathways and Potential Targets of Luteolin Treatment on Late-Onset Depression Based on Cerebrospinal Fluid Proteomics
Kaige Liu, Huizhen Li, Ning-Xi Zeng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3485-3485
Open Access | Times Cited: 11

Scroll to top